Ranjit Bindra,MD/PhD

Harvey & Kate Cushing Professor at Yale; Co-Director, Yale Brain Tumor Center; CNS RadOnc; Biotech Entrepreneur; Surprisingly good drummer…

[Ranjit Bindra,MD/PhD @ranjitbindra]

🙏🏽🙌🏽

[The Sontag Foundation @sontagfdn]

The @SontagFund marks a major #braincancer milestone: @YaleMed research by Dr. @ranjitbindra led to @modifibio. In 2024, @Merck acquired Modifi Bio to continue development of this promising molecule.

Read more: https://t.co/5rohyfDirF

[Yale Cancer Center @YaleCancer]

Inspired by 12y/o patient Avery Lafferty, @ranjitbindra + his team developed KL-50, a novel new #glioblastoma therapy. Now acquired by @Merck, KL-50 is advancing through FDA safety studies, w/hopes for a Phase I trial next fall.
https://t.co/tiXOvEv0oC
@SmilowCancer @YaleNeuro

[Ranjit Bindra,MD/PhD @ranjitbindra]

This story highlights how academic discovery can become real therapeutic promise through biotech innovation and pharma partnership. For brain tumors, where progress has been far too slow, it shows what is possible when science is allowed to move forward.

https://t.co/rUFVVnw1IW

[Ranjit Bindra,MD/PhD @ranjitbindra]

Our star postdoc presenting at #ASH25!

[Yale Cancer Center @YaleCancer]

~25–30% of #AML has MGMT silencing—a targetable vulnerability. New research presented by @Prateek_Bhardwj identifies KL50, a novel crosslinking compound, as highly potent in MGMT-silenced AML. The data shared #ASH25 strongly supports MGMT-guided clinical trials of KL50. @Halene_lab @ranjitbindra @YaleHematology @ASH_hematology

[Ranjit Bindra,MD/PhD @ranjitbindra]

Our latest bench-to-bedside trial is out! Testing a CNS-penetrant PARPi+TMZ in rec IDHm Glioma! Lays the groundwork for a number of studies in the coming years 🙌🏽
@YaleRadOnc
@YaleCancer
@UVACancerCenter
@karmanoscancer
#gbm #glioma #precisiononcology

https://t.co/5GeOj5xFLb

[Ranjit Bindra,MD/PhD @ranjitbindra]

Another fabulous ASTRO on the books with the @YaleRadOnc team!

[Yale Radiation Oncology Residency @YaleRadOnc]

Yale Therapeutic Radiology has made it to #ASTRO25! Excited to learn, collaborate, and showcase our own work in the great city of San Francisco! 🌁

[Yale Radiation Oncology Residency @YaleRadOnc]

Yale Therapeutic Radiology has made it to #ASTRO25! Excited to learn, collaborate, and showcase our own work in the great city of San Francisco! 🌁

[Ranjit Bindra,MD/PhD @ranjitbindra]

Congrats to a phenomenal Bindra Lab alum, and to the Vasquez Lab!

[Juan Vasquez, MD @JcvasqV]

Honored to receive this award! Grateful to @YalePediatrics @YaleCancer @SmilowCancer and to past and current mentors, particularly @ranjitbindra for their support. Excited to move forward in developing new therapies for children with cancer!

[Ranjit Bindra,MD/PhD @ranjitbindra]

Very proud of this star Bindra Lab student 🙌🏽🙏🏽

[Yale Cancer Center @YaleCancer]

James Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.”
https://t.co/BD8gU4oeIz
@SmilowCancer @ranjitbindra

[Ranjit Bindra,MD/PhD @ranjitbindra]

Very excited for this Bindra Lab star! 🙌🏽🙏🏽

[Yale Cancer Center @YaleCancer]

James Elia @yalepathology has been awarded a prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Award #F31 from @NIH for his project, “Exploiting Homologous Recombination Defects with a Novel DNA-Crosslinking Strategy.”
https://t.co/BD8gU4oeIz
@SmilowCancer @ranjitbindra

[Ranjit Bindra,MD/PhD @ranjitbindra]

Yale RadOnc is recruiting a Physician-Scientist!

Come join a vibrant community of basic & translational scientists working alongside clinician-investigators & clinicians. Please apply directly via the link below!

@YaleRadOnc
@YaleCancer
@ASTRO_org

https://t.co/c2BwX0FkUF

[Henry S. Park, MD, MPH @HenryParkMD]

Congrats to my fantastic colleagues Dr. Faye Rogers (professor) as well as Drs. Yi An, Julie Kang, and Tim Robinson (associate professor) for your promotions @YaleRadOnc @YaleCancer @YaleMed! I’m honored to continue working with you all.

[Ranjit Bindra,MD/PhD @ranjitbindra]

Well deserved! 🙌🏽

[Henry S. Park, MD, MPH @HenryParkMD]

Grateful to be promoted to full professor @YaleMed! I truly appreciate all the support along the way, including from countless mentors, colleagues, letter writers, trainees, friends, and family, especially my parents and wife. I plan to pay it forward! @YaleCancer @YaleRadOnc

[Henry S. Park, MD, MPH @HenryParkMD]

Grateful to be promoted to full professor @YaleMed! I truly appreciate all the support along the way, including from countless mentors, colleagues, letter writers, trainees, friends, and family, especially my parents and wife. I plan to pay it forward! @YaleCancer @YaleRadOnc

[Ranjit Bindra,MD/PhD @ranjitbindra]

Congrats on a wonderful talk!

[Angela Kim @AngKim99]

Had an amazing time at @YaleCancer 8th annual symposium! I had the honor of presenting our work on NAPRT-loss in pediatric rhabdomyosarcoma.

All thanks to my amazing mentors, @JcvasqV and @ranjitbindra, as well as all the collaborators 🙌

@Shahyan_Rehman @yalepathology

[Angela Kim @AngKim99]

Had an amazing time at @YaleCancer 8th annual symposium! I had the honor of presenting our work on NAPRT-loss in pediatric rhabdomyosarcoma.

All thanks to my amazing mentors, @JcvasqV and @ranjitbindra, as well as all the collaborators 🙌

@Shahyan_Rehman @yalepathology

[ESMO - Eur. Oncology @myESMO]

Don’t miss the next YO4YO Virtual Session with @ranjitbindra & @ekocakavuk
📌 How to move from bedside to bench to biotech
📅 8 July 2025
🕒 15:00–16:00 CEST

🔗 https://t.co/Wy2IJsCuIt

[Ranjit Bindra,MD/PhD @ranjitbindra]

Fabulous work from a fabulous grad student 🙌🏽

[Yale Cancer Center @YaleCancer]

New research led by James Elia #BindraLab @ranjitbindra, led to development of a pioneering, free software application #CellPyAbility, a tool to simplify + enhance analysis of cell viability data.
https://t.co/EdwwE3U8pI
@SmilowCancer @YaleMed @YNHH #NCRM25 #unitedbycancerresearch @AACR

[CURE Today @cure_today]

#BrainCancer Awareness Month Highlights Advances in Radiation Therapy @ranjitbindra https://t.co/4ttQs6GYLu

[Ranjit Bindra,MD/PhD @ranjitbindra]

@YaleCancer
@YaleRadOnc

[CURE Today @cure_today]

Advances in Radiation Improve Precision in Brain Cancer Therapy #Oncology #BrainCancer #MedTwitter

Watch more from @ranjitbindra, of @YaleCancer/@YaleMed here: https://t.co/IXAhkFLcwE